Antibiotics for lower respiratory tract infection in children presenting in primary care (ARTIC-PC): the predictive value of molecular testing

Paul Little(University of Antwerp), Theo Verheij(Utrecht University), Nick Francis(University of Oxford), Natalie Thompson(University of Toronto), Michael Moore(Indiana University School of Medicine), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Alastair D Hay(University of Bristol), Gilly O’Reilly(University of Southampton), Taeko Becque(University of Southampton), Robert C. Read(University Hospital Southampton NHS Foundation Trust), Kay Wang(University of Oxford), Beth Stuart(Queen Mary University of London), Kerenza Hood(NHS Digital)
Clinical Microbiology and Infection
March 11, 2022
10.1016/j.cmi.2022.02.033
Cited by 6

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k